COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada
Stopped Study Withdrawn
Conditions
Interventions
- DRUG: Hydroxychloroquine
- DRUG: Placebo
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's